Exchange: NASDAQ·Updated 06:43 PM EDT

GEHC News

News
all
press releases
GE HealthCare to announce third quarter 2026 results on October 28, 2026
GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2026 financial results before the market opens on Wednesday, October 28, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will...
Business Wire
GE HealthCare to announce third quarter 2026 results on October 28, 2026
GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2026 financial results before the market opens on Wednesday, October 28, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will...
Business Wire
More News
GE HealthCare Expands U.S. PET Radiopharma Reach With SOFIE Deal
GEHC's $945M SOFIE Biosciences deal will expand its U.S. PET radiopharmaceutical footprint and boost exposure to precision care growth.
Zacks
GE HealthCare To Acquire SOFIE Biosciences For $945M — Here’s What GEHC Investors Need To Know
GE HealthCare is adding SOFIE’s PET radiopharmaceutical manufacturing footprint and U.S. rights to FAPI-74 as it expands its presence in precision diagnostics.
Stocktwits
Here's How Tempus AI is Capitalizing on AI-ECG Market Growth
TEM is expanding its cardiovascular portfolio with FDA-cleared AI-ECG tools targeting complex cardiac conditions.
Zacks
GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.
GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027...
Business Wire
GEHC vs. SYK: Which Stock Should Value Investors Buy Now?
GEHC vs. SYK: Which Stock Is the Better Value Option?
Zacks
GE HealthCare (GEHC) Upgraded to Buy: Here's Why
GE HealthCare (GEHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
Here's Why You Should Add GEHC Stock to Your Portfolio Right Now
GEHC's record backlog, strong orders and AI-enabled innovations offer growth potential, while inflation and China remain key risks.
Zacks
GE HealthCare announces cash dividend increase for third quarter of 2026
The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.04 per share of Common Stock for the third quarter of 2026, an increase of 14% from the previous quarter. The dividend will be payable on November 13, 2026, to all shareholders of record as...
Business Wire
GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors
GE HealthCare (Nasdaq: GEHC) today announced the appointment of Pascal Desroches, Senior Executive Vice President and Chief Financial Officer (CFO) of AT&T (NYSE: T), a Fortune 50 company, to its Board of Directors, effective January 4, 2027. Mr. Desroches brings more than 30 years of leadership...
Business Wire

Advertisement|Remove ads.